Top News

• FDA Warns Firm Marketing Blood Pressure Estimator
• Anselamimab Trial Misses Primary Endpoint in Amyloidosis
• New Orphan Product Grant Funding Opportunity
• 7 Observations in Natco Pharma FDA-483
• Guide to Characterize Combination Cancer Drugs
• CGMP Violations Cited in Daewoo Warning
• FDA Inspection Backlog Can Hurt Canada: Analysis
• Ocular Toxicity Concerns with Multiple Myeloma Drug: FDA